Client News

France Biotech: A new Patient-Centered Endowment Fund launched by France Biotech: “HealthTech For Care”

BIO-Europe Spring® 2020 Stages Largest Fully Digital Life Science Partnering Event with Great Success

InflaRx Doses First Patient in Multicenter Randomized Clinical Trial in Severe Progressed COVID-19 Pneumonia in Europe upon Receipt of Initial Positive Human Data with InflaRx’s anti-C5a Technology

Newron AGM Result and Clinical and Business Update

Verona Pharma Reports Positive Efficacy and Safety Data with Single Dose pMDI Formulation of Ensifentrine in COPD

Heidelberg Pharma AG: European Patent Office Grants Patent for Amatoxin Conjugates for Tumor Therapy

Heidelberg Pharma AG: Heidelberg Pharma Publishes Article on Chemical Amanitin Synthesis in Angewandte Chemie Journal

Newly published data in Cancer Immunology, Immunotherapy support the potential of Secarna Pharmaceuticals’ LNA-modified ASOs to effectively block important immunosuppressive pathway

CENTOGENE AG: CENTOGENE startet Pilotprojekt zur Diagnose von unentdeckten Covid-19-Fällen

Secarna Pharmaceuticals announces the acquisition of LNAplusTM based antisense drug candidates by Lipigon Pharmaceuticals